No Data
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
Zhongsu Hong Kong Stock Repurchase Statistics | February 14
Hong Kong stock repurchase Statistics | February 14
On February 13, Microtech Medical-B (02235.HK) spent 0.1401 million Hong Kong dollars to repurchase 0.029 million shares.
On February 13, Glorious Group announced that Weitai Medical-B (02235.HK) spent 0.1401 million HKD to buy back 0.029 million shares, with a repurchase price per share ranging from 4.68 to 4.96 HKD.
AI hotspots continue to boost! Most Medical stocks in Hong Kong strengthen, with Micro-invasion Siasun Robot&Automation rising over 20%.
How does Sister Wood perceive this hot topic of AI Medical? What positive impacts will the emergence of DeepSeek bring to the medical field?
On February 4, Weitai Medical-B (02235.HK) spent HKD 0.14 million to repurchase 0.0277 million shares.
Gelonghui February 4丨Weitai Medical-B (02235.HK) announced that on February 4, it spent 0.14 million Hong Kong dollars to repurchase 0.0277 million shares.
